Pictet Asset Management Holding SA Sells 22,407 Shares of Molina Healthcare, Inc $MOH

Key Points

• Pictet Asset Management cut its stake in Molina Healthcare (MOH) by 65.7%, selling 22,407 shares and leaving it with 11,719 shares valued at about $2.03 million.
• Molina beat quarterly EPS expectations with $2.35 vs. $1.57 expected while revenue of $10.80 billion slightly missed estimates, and the company set FY2026 EPS guidance around 5.00 (sell‑side analysts average ~5.21 EPS).
• MOH has a market cap of about $10.18 billion and a P/E of ~57.8, with a consensus analyst rating of "Hold" and a consensus price target of $169.60.

Pictet Asset Management Holding SA lessened its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 65.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,719 shares of the company's stock after selling 22,407 shares during the quarter. Pictet Asset Management Holding SA's holdings in Molina Healthcare were worth $2,034,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Miller Global Investments LLC bought a new stake in Molina Healthcare in the fourth quarter valued at about $27,000. Cromwell Holdings LLC increased its holdings in Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company's stock valued at $32,000 after purchasing an additional 125 shares during the last quarter. Bogart Wealth LLC bought a new stake in Molina Healthcare in the third quarter valued at about $39,000. Rakuten Securities Inc. increased its holdings in Molina Healthcare by 5,020.0% in the fourth quarter. Rakuten Securities Inc. now owns 256 shares of the company's stock valued at $44,000 after purchasing an additional 251 shares during the last quarter. Finally, MUFG Securities EMEA plc acquired a new position in Molina Healthcare in the second quarter valued at about $48,000. Institutional investors own 98.50% of the company's stock.

Molina Healthcare Stock Up 1.4%

MOH stock opened at $195.40 on Tuesday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The stock has a market capitalization of $10.18 billion, a P/E ratio of 57.81 and a beta of 0.85. The business has a 50-day moving average of $149.82 and a 200-day moving average of $158.47. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $333.00.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.78. The company had revenue of $10.80 billion during the quarter, compared to analysts' expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.Molina Healthcare's revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, sell-side analysts anticipate that Molina Healthcare, Inc will post 5.21 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MOH has been the subject of a number of research analyst reports. Morgan Stanley boosted their target price on Molina Healthcare from $128.00 to $146.00 and gave the company an "equal weight" rating in a research note on Friday, April 24th. Mizuho decreased their target price on Molina Healthcare from $220.00 to $180.00 and set an "outperform" rating for the company in a research note on Thursday, March 12th. Cantor Fitzgerald decreased their target price on Molina Healthcare from $180.00 to $144.00 and set a "neutral" rating for the company in a research note on Monday, February 9th. UBS Group boosted their target price on Molina Healthcare from $151.00 to $180.00 and gave the company a "neutral" rating in a research note on Friday, April 24th. Finally, Wells Fargo & Company boosted their target price on Molina Healthcare from $141.00 to $159.00 and gave the company an "equal weight" rating in a research note on Monday, April 27th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, Molina Healthcare presently has a consensus rating of "Hold" and a consensus price target of $169.60.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.